| Gene symbol | ITIH4 | Synonyms | GP120, H4P, IHRP, ITI-HC4, ITIHL1, PK-120, PK120 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3p21.1 | dbXrefs | |
| Description | inter-alpha-trypsin inhibitor heavy chain 4 | ||||
| GTO ID | GTC0934 |
| Trial ID | ChiCTR2100047544 |
| Disease | HIV-1 Infection |
| Altered gene | gp120 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | gp120 CAR-T cells |
| Co-treatment | HAART |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An single-center, open-label and case control clinical study to evaluate safety and efficacy of Anti-gp120 CAR-T cells plus HAART regimen for newly treated patient infection |
| Year | 2021 |
| Country | China |
| Company sponsor | Kunming Third People's Hospital |
| Cohort 1 | |||||||
|
|||||||